The Patent Finder

Terms ending in 2029

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,288,339GLP-1 Compounds
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,946,152Method of Treating Parkinson's Disease in Humans by Convection-Enhanced Infusion of Glial Cell-Line Derived Neurotrophic Factor to the Putamen
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 9,175,078Ferroportin Antibodies and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 9,688,759Ferroportin Antibodies and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,221,749Antibodies Directed to ANGIOPOIETIN-1 and ANGIOPOIETIN-2 and Uses Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,336,820Antibodies Directed to ANGIOPOIETIN-1 and ANGIOPOIETIN-2 and Uses Thereof
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US D723,157Drug Delivery Pump
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 8,093,299Methods of Treating Bowel Disorders
In force
 · High confidence
Yale UniversityIn forceHigh confidence
US 7,947,809Compositions and Methods Relating to Glucagon Receptor Antibodies
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 7,960,567Compounds and Methods Useful for Treating Asthma and Allergic Inflammation
In force
 · High confidence
Amgen Inc.In forceHigh confidence
46 more term ends in 2029 · Pro
10 of 56 patents shown. Soonest term end first, then patent number.
Pro members see all 56.
Upgrade to Pro
52 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited